After the bladder is surgically removed and the urinary system diverted, most can return to their usual activities. When William O’Brien was diagnosed with bladder cancer at 75, he fit the profile of ...

Perioperative enfortumab vedotin plus pembrolizumab and surgery lead to significantly better outcomes among patients with ...

RARC with intracorporeal urinary diversion offers survival outcomes similar to those of open radical cystectomy, but is associated with better perioperative outcomes. Real-world data support the ...

Abstract PURPOSE: To evaluate our long-term experience with patients treated uniformly with radical cystectomy and pelvic lymph node dissection for invasive bladder cancer and to describe the ...

Prophylactic tranexamic acid showed no reduction in blood transfusion rates in open radical cystectomy patients. The trial found no significant differences in secondary outcomes, including estimated ...

Regimen significantly improved survival over standard neoadjuvant chemotherapy ...

Following radical cystectomy for bladder cancer, end-stage renal disease patients are 3-4 times more likely to die from causes other than cancer. The following article is part of conference coverage ...

Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced it will present new ...

Bladder cancer is the fourth most commonly diagnosed cancer in men in the United States and the 10th leading cause of cancer deaths. Many treatments can be used for bladder cancer, and the kind of ...